DTRT Health Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders
December 01 2022 - 4:06PM
Business Wire
DTRT Health Acquisition Corp. (“we”, “us”,
“our”, or the “Company”) today announced that it convened and
then adjourned, without conducting any other business, its special
meeting of stockholders (the “Special
Meeting”) held on December 1, 2022. The Special Meeting has
been adjourned from December 1, 2022 to December 6, 2022 at 3:00
p.m. Central Time. The Special Meeting is being adjourned in order
to provide additional time that is necessary in order to effectuate
the amendment of the Company's amended and restated certificate of
incorporation ("Extension Amendment") to extend the period of time
available to complete a business combination, until March 7,
2023.
The record date for the stockholders' meeting to vote on the
Extension Amendment remains the close of business on October 24,
2022 (the "Record Date"). Stockholders who have previously
submitted their proxy or otherwise voted and who do not want to
change their vote need not take any action. Stockholders as of the
Record Date can vote, even if they have subsequently sold their
shares.
About DTRT Health Acquisition Corp.
We are a blank check company incorporated under the laws of the
State of Delaware on April 19, 2021, for the purpose of effecting a
merger, share exchange, asset acquisition, stock purchase,
recapitalization, reorganization, or similar business combination
with one or more businesses, which we refer to throughout this
proxy statement as our initial business combination. While we may
pursue our initial business combination target in any stage of its
corporate evolution or in any industry or sector, we are focusing
our search on companies with favorable growth prospects and
attractive returns on invested capital.
Additional Information and Where to Find It
The definitive proxy statement has been mailed to the Company's
stockholders. INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ
THE DEFINITIVE PROXY STATEMENT AND OTHER RELEVANT MATERIALS BECAUSE
THEY CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY. Investors and
security holders may obtain free copies of these documents and
other documents filed with the SEC at the SEC's web site at
www.sec.gov. In addition, the documents filed by the Company with
the SEC may be obtained free of charge by directing a request to
DTRT’s secretary at 1415 West 22nd Street, Tower Floor, Oak Brook,
IL 60523, (312) 316-5473.
Participants in the Solicitation
The Company and its sponsor, officers and directors may be
deemed to be participants in the solicitation of proxies from
Company stockholders. Information about the Company’s sponsor,
officers and directors and their ownership of Company common stock
is set forth in the proxy statement for Company’s Special Meeting
of Stockholders, which was filed with the SEC on October 31, 2022,
and in the Company’s Annual Report on Form 10-K for the year ended
December 31, 2021, which was filed with the SEC on April 1, 2022.
Investors and security holders may obtain more detailed information
regarding the direct and indirect interests of the participants in
the solicitation of proxies in connection with the transaction by
reading the Registration Statement on Form S-4 regarding the
transaction, which was filed by Grizzly New Pubco, Inc. with the
SEC on October 20, 2022.
Non-Solicitation
This Current Report on Form 8-K is not a proxy statement or
solicitation of a proxy, consent or authorization with respect to
any securities or in respect of the proposed Extension Amendment
shall not constitute an offer to sell or a solicitation of an offer
to buy the securities of the Company, nor shall there be any sale
of any such securities in any state or jurisdiction in which such
offer, solicitation, or sale would be unlawful prior to
registration or qualification under the securities laws of such
state or jurisdiction. No offer of securities shall be made except
by means of a prospectus meeting the requirements of Section 10 of
the Securities Act of 1933, as amended.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221201005995/en/
DTRT Health Acquisition Corp. Contact: Arion Robbins
arobbins@dtrthealth.com www.dtrthealth.com
DTRT Health Acquisition (NASDAQ:DTRT)
Historical Stock Chart
From Oct 2024 to Nov 2024
DTRT Health Acquisition (NASDAQ:DTRT)
Historical Stock Chart
From Nov 2023 to Nov 2024